A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations

Human Brain Mapping

Volumn 35, Issue 4, 2014, Pages 1226-1236

  Roussotte, Florence F ^a,b   Jahanshad, Neda ^a   Hibar, Derrek P ^a   Sowell, Elizabeth R ^b   Kohannim, Omid ^a   Barysheva, Marina ^a   Hansell, Narelle K ^c   Mcmahon, Katie L ^d   de Zubicaray, Greig I ^d   Montgomery, Grant W ^c   Martin, Nicholas G ^c   Wright, Margaret J ^c   Toga, Arthur W ^a   Jack, Clifford R ^e   Weiner, Michael W ^f   Thompson, Paul M ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug addiction; Genetics; Neurodegeneration; Neuroimaging; Opiates

Indexed keywords

AMYLOID PROTEIN; DELTA OPIATE RECEPTOR; TAU PROTEIN; BIOLOGICAL MARKER; OPRD1 PROTEIN, HUMAN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN REGION; BRAIN SIZE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROIMAGING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; AGING; CLINICAL TRIAL; FACTUAL DATABASE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOTYPING TECHNIQUE; IMAGE PROCESSING; MILD COGNITIVE IMPAIRMENT; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; TWINS; YOUNG ADULT;

AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; DATABASES, FACTUAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINKAGE DISEQUILIBRIUM; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, DELTA; TWIN STUDIES AS TOPIC; YOUNG ADULT;

EID: 84896395479     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22247     Document Type: Article

References (50)

1. Aron JL, Paulus MP (2007): Location, location: Using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction 102(Suppl 1):33-43.
2. Barrett JC, Fry B, Maller J, Daly MJ (2005): Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
3. Barson JR, Carr AJ, Soun JE, Sobhani NC, Rada P, Leibowitz SF, Hoebel BG (2010): Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol Clin Exp Res 34:214-222.
4. Blokland GA, McMahon KL, Thompson PM, Martin NG, De Zubicaray GI, Wright MJ (2011): Heritability of working memory brain activation. J Neurosci 31:10882-10890.
5. Chung MK, Worsley KJ, Paus T, Cherif C, Collins DL, Giedd JN, Rapoport JL, Evans AC (2001): A unified statistical approach to deformation-based morphometry. Neuroimage 14:595-606.
6. Collins DL, Neelin P, Peters TM, Evans AC (1994): Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192-205.
7. Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, Berrettini WH(2012): Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend.
8. De Zubicaray GI, Chiang MC, McMahon KL, Shattuck DW, Toga AW, Martin NG, Wright MJ, Thompson PM (2008): Meeting the challenges of neuroimaging genetics. Brain Imaging Behav 2:258-263.
9. Feng Y, Chao D, He X, Yang Y, Kang X, Lazarus LH, Xia Y (2009): A novel insight into neuroprotection against hypoxic/ischemic stress. Sheng Li Xue Bao 61:585-592.
10. Freeborough PA, Fox NC (1998): Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr 22:838-843.
11. Gutman B, Svarer C, Leow AD, Yanovsky I, Toga AW, Thompson PM (2010):Creating Unbiased Minimal Deformation Templates for Brain Volume Registration. Organization For Human Brain Mapping, Barcelona, Barcelona, Spain, June 2010.
12. Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N (2005): Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135:213-225.
13. Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CRJr, Weiner MW, Thompson PM (2008a): Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects. Neuroimage 43:458-469.
14. Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CRJr Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM and the Alzheimer's Disease Neuroimaging, Initiative (2008b): 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 41:19-34.
15. Jack CRJr Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, LWhitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW (2008): The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685-691.
16. Jahanshad N, Kohannim O, Hibar DP, Stein JL, McMahon KL, de Zubicaray GI, Medland SE, Montgomery GW, Whitfield JB, Martin NG, Wright MJ, Toga AW, Thompson PM (2012): Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci USA 109:E851-E859.
17. Janecka A, Fichna J, Janecki T (2004): Opioid receptors and their ligands. Curr Top Med Chem 4:1-17.
18. Jenkinson M, Bannister P, Brady M, Smith S (2002): Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825-841.
19. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A (2006): Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data. Neuroimage 30:436-443.
20. Kang HM, Sul JH, Service SK, Zaitlen NA, Kong SY, Freimer NB, Sabatti C, Eskin E (2010): Variance component model to account for sample structure in genome-wide association studies. Nat Genet 42:348-354.
21. Kohannim O, Jahanshad N, Braskie MN, Stein JL, Chiang MC, Reese AH, Hibar DP, Toga AW, McMahon KL, de Zubicaray GI, Medland SE, Montgomery GW, Martin NG, Wright MJ, Thompson PM (2012): Predicting white matter integrity from multiple common genetic variants. Neuropsychopharmacology 37:2012-2019.
22. Lander ES, Schork NJ (1994): Genetic dissection of complex traits. Science 265:2037-2048.
23. Langers DR, Jansen JF, Backes WH (2007): Enhanced signal detection in neuroimaging by means of regional control of the global false discovery rate. Neuroimage 38:43-56.
24. Leow A, Huang SC, Geng A, Becker J, Davis S, Toga A, Thompson P (2005): Inverse consistent mapping in 3D deformable image registration: Its construction and statistical properties. Inf Process Med Imaging 19:493-503.
25. Leow AD, Klunder AD, Jack CRJr Toga AW, Dale AM, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Whitwell JL, Borowski BJ, Fleisher AS, Fox NC, Harvey D, Kornak J, Schuff N, Studholme C, Alexander GE, Weiner MW, Thompson PM (2006): Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 31:627-640.
26. Levran O, Yuferov V, Kreek MJ (2012): The genetics of the opioid system and specific drug addictions. Hum Genet 131:823-842.
27. London ED, Ernst M, Grant S, Bonson K, Weinstein A (2000): Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 10:334-342.
28. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B (2001): A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 356:1293-1322.
29. Nielsen CK, Simms JA, Li R, Mill D, Yi H, Feduccia AA, Santos N, Bartlett SE (2012): Delta-opioid receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats. J Neurosci 32:4540-4552.
30. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL (2011): The delta opioid receptor: An evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32:581-590.
31. Riddle WR, Li R, Fitzpatrick JM, Donlevy SC, Dawant BM, Price RR (2004): Characterizing changes in MR images with color-coded Jacobians. Magn Reson Imaging 22:769-777.
32. Sarajarvi T, Tuusa JT, Haapasalo A, Lackman JJ, Sormunen R, Helisalmi S, Roehr JT, Parrado AR, Makinen P, Bertram L, Soininen H, Tanzi RE, Petaja-Repo UE, Hiltunen M (2011): Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Mol Cell Biol 31:2326-2340.
33. Schellenberg GD, Montine TJ (2012): The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol 124:305-323.
34. Sled JG, Zijdenbos AP, Evans AC (1998): A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97.
35. Smith SM (2002): Fast robust automated brain extraction. Hum Brain Mapp 17:143-155.
36. Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CRJr, Weiner MW, Thompson PM (2010): Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage 51:542-554.
37. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann O, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, and others (2012): Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44:552-561.
38. Tanabe J, Tregellas JR, Dalwani M, Thompson L, Owens E, Crowley T, Banich M (2009): Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry 65:160-164.
39. Teng L, Zhao J, Wang F, Ma L, Pei G (2010): A GPCR/secretase complex regulates beta- and gamma-secretase specificity for abeta production and contributes to AD pathogenesis. Cell Res 20:138-153.
40. Thompson PM, Giedd JN, Woods RP, Macdonald D, Evans AC, Toga AW (2000): Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404:190-193.
41. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CRJr Jagust W, Toga AW, Lee VM, Shaw LM (2010): Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's Dement 6:230-238.
42. Van Holst RJ, De Ruiter MB, Van Den Brink W, Veltman DJ, Goudriaan AE (2012): A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug Alcohol Depend 124:142-148.
43. Van Rijn RM, Brissett DI, Whistler JL (2010): Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther 335:133-139.
44. Van Rijn RM, Brissett DI, Whistler JL (2012a): Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry 71:232-238.
45. Van Rijn RM, Brissett DI, Whistler JL (2012b): Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists. Drug Alcohol Depend 122:156-159.
46. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R (2011): Food and drug reward: Overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci 1:1-24.
47. Wright MJ, Martin NG (2004): Brisbane adolescent twin study: Outline of study methods and research projects. Aust J Psychol 56:65-78.
48. Wu Y, Chen R, Zhao X, Li A, Li G, Zhou J (2011): JWA regulates chronic morphine dependence via the delta opioid receptor. Biochem Biophys Res Commun 409:520-525.
49. Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J (2008): The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13:531-543.
50. Zhang X, Bao L, Guan JS (2006): Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27:324-329.